Welcome Back! We have recently partnered with Psych Congress to bring our audience access to some of their leading speakers and educators, and today we will be speaking to the distinguished Dr. Rakesh Jain on the topic of Positive Psychiatry.
Psych Congress Discount Code: PSYCHROUNDS
Conference Website: https://www.hmpglobalevents.com/psych-congress
Check out Dr. Jain’s podcast “Positive Psychiatry - with Rakesh Jain, MD”:
Spotify: https://open.spotify.com/show/0Yk8QVD1wnLxMBM4zJDuJ5?si=wpUCJnAqR7qk9CW8gN90sQ
Apple: https://podcasts.apple.com/us/podcast/positive-psychiatry-with-rakesh-jain-md/id1822146163
Sources:
- WHO-5: https://www.who.int/publications/m/item/WHO-UCN-MSD-MHE-2024.01
- Demyttenaere et. al (2015): https://pubmed.ncbi.nlm.nih.gov/25545606
- Dr. Jain's website: http://www.rakeshjainmd.com/
Welcome back! Today we are looking at the beta-blocker Propranolol, also known by its brand name, Inderal. Although this medication is sometimes used as an anti-hypertensive, we are going to look at its use in psychiatry and anxiety disorders.
Sources
On today's episode, we will be discussing Buspirone (Buspar), a commonly used medication for anxiety.
References:
Today, we have one of the giants and pioneers of Asian-American Psychiatry joining us to discuss Cultural Psychiatry, Dr. Francis Lu!
Dr. Lu's Books: https://www.amazon.com/stores/author/B003HFAX8E?ccs_id=d6d03eae-2c95-481f-8f7a-f844580eb108
References:
https://psychiatryonline.org/doi/10.1176/appi.focus.18103
https://psycnet.apa.org/record/2015-37696-000
Welcome back! On todays episode, we will discuss hydroxyzine (Atarax, Vistaril), a frequently used medication for anxiety.
References:
https://pubmed.ncbi.nlm.nih.gov/9616188/
https://pubmed.ncbi.nlm.nih.gov/27998379/
https://pubmed.ncbi.nlm.nih.gov/21154375/
https://pubmed.ncbi.nlm.nih.gov/1345410/
We're back from our brief hiatus! Today, we are hosting Dr. Matthew Bernstein to talk about a rising subfield of psychiatry - Metabolic Psychiatry. We'll be looking at its history, the ketogenic diet, mitochondria, and more!
References
- https://pubmed.ncbi.nlm.nih.gov/38273108/
- https://pubmed.ncbi.nlm.nih.gov/34113269/
- https://pubmed.ncbi.nlm.nih.gov/39296512/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12089804/
- https://pubmed.ncbi.nlm.nih.gov/40043464/
- https://pubmed.ncbi.nlm.nih.gov/28137247/
Metabolic Mind: https://www.metabolicmind.org/
Free CME: https://www.mycme.com/courses/ketogenic-therapy-treatment-for-serious-mental-illness-10028
Baszucki Group: https://baszuckigroup.com/
Welcome to today's episode on the salience network, the final episode in our three-part series on neural networks. We'll explore how the salience network helps the brain prioritize what matters most by filtering relevant stimuli.
On todays episode we will be discussing Transcranial Magnetic Stimulation with a very special guest, Dr. Jonathan Downar. We will also discuss the ONE-D and THREE-D trails.
Three-D Trial: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30295-2/abstract’
One-D Trial: https://www.researchsquare.com/article/rs-5679327/v1
SAINT TMS: https://psychiatryonline.org/doi/10.1176/appi.ajp.2019.19070720
On today's episode, we continue our series with a discussion of the Central Executive Network, following our previous episode on the Default Mode Network.
References:
On today's episode we have a special international guest, Dr. Pouya Movahed Rad from Lund University in Sweden. We will be discussing Electroconvulsive therapy (ECT) and the Ket-ECT, and ELEKT-D studies.
Comparison: https://pubmed.ncbi.nlm.nih.gov/38114073/
Join us today as we venture into the Triple Network Model as a basis for psychiatric illness, starting with the Default Mode Network.
References
Welcome back! Today we will be discussing Metformin and some of the recent guidelines published in the journal the Schizophrenia Bulletin. (Carolan et. al 2024).
On today’s special guest episode, we’ll be exploring the topic of nitrous oxide with Dr. Charles Conway and Dr. Vasilis Hristidis.
https://medicine.washu.edu/news/laughing-gas-relieves-symptoms-in-people-with-treatment-resistant-depression/
https://pmc.ncbi.nlm.nih.gov/articles/PMC5825282/
https://pubmed.ncbi.nlm.nih.gov/34108247/
https://pubmed.ncbi.nlm.nih.gov/25577164/
In today’s episode, we explore ketamine’s therapeutic potential with Dr. Joshua Rosenblat, a leading expert and faculty member at the University of Toronto’s Department of Psychiatry (learn more).
https://x.com/jd_rosenblat?lang=en
https://pubmed.ncbi.nlm.nih.gov/35688035/
https://pubmed.ncbi.nlm.nih.gov/39608193/
Welcome back! Today, we are discussing a new branded medication that combines bupropion with dextromethorphan for the treatment of depression.
Today, we will be discussing tricyclic antidepressants (TCA's). Once again, we've picked a few of our favorites to discuss on today's episode.
Welcome back! Today, we will be discussing MAOIs, and we've picked out a few of our favorites for today's episode.
Could there be an evolutionary perspective for depression? Join us for part two of our series on depression and inflammation.
Join us as we talk about the relationship between depression and inflammation - an interesting biological theory.
Join us as we talk about Loxapine, an older medication that’s stood the test of time and found a niche in psychiatric practice.
